Pesquisa e Desenvolvimento
Working for our patients
Our Research & Development teams are determined to discover, develop, and deliver medicines that have the potential to transform the lives of patients and establish new standards of care in the areas of high unmet needs. We are creating life-changing medicine to eliminate some of the world’s most formidable diseases with a focus on oncology, hematology, cardiovascular, immunology and neuroscience. This isn’t easy work, but it is uniquely interesting. This is where you will rewrite the rules, solve the toughest challenges, and create miracles.
Explore careers in Research & Development
Estamos orgulhosos dos progressos que fizemos em nossas principais áreas terapêuticas de oncologia, hematologia, imunologia, cardiovascular e neurociência. Nosso portfólio diversificado e promissor está focado em pesquisas em áreas terapêuticas onde acreditamos ter a melhor oportunidade de fornecer medicamentos transformacionais aos pacientes. A BMS é o lugar ideal quando se trata de desenvolver a próxima geração de terapias inovadoras que transformam vidas. Sua experiência envolverá um trabalho interessante, um crescimento empolgante na carreira, e companheiros de equipe talentosos que são líderes em suas áreas. Quem sabe também transformará sua carreira?
Our next neuroscience breakthrough need authors
Neurological and neuropsychiatric conditions are complex and present significant challenges in healthcare today. These disorders are often long-lasting and difficult to treat, causing a major impact on patients, caregivers, and families.
At Bristol Myers Squibb, you will be part of a team working to address some of the toughest neurological issues, creating real change for those affected. Our mission is to lead in innovation by developing new treatments that can slow the progress of these diseases and improve quality of life for patients and those who support them.
Discover the innovation of RayzeBio.
RayzeBio is a dynamic biotechnology company headquartered in San Diego, CA. Launched in late 2020 and recently acquired by Bristol Myers Squibb (BMS) as a wholly owned subsidiary, the company is focused on improving survival of people with cancer by harnessing the power of targeted radioisotopes.
RayzeBio will operate as a standalone entity within the BMS organization, maintaining its biotech culture with the opportunity to leverage the best-in-class oncology capabilities of BMS. RayzeBio is developing innovative drugs against targets of solid tumors.
Junte-se a Nossa Comunidade de Talentos
Sua carreira pode ter significado. Seu trabalho pode mudar vidas. Junte-se a nossa comunidade de talentos hoje para que possamos manter contato sobre nossas oportunidades de carreira excepcionalmente interessantes. A transformação começa aqui.


